Schedule 13G ownership disclosure
ACADIA Pharmaceuticals Inc
Common Stock · CUSIP: 004225108
Event date: 2025-01-31
- Filing-level shares
- 19,878,746
- Percent of class
- 11.9%
- BlackRock, Inc.
Shares: 19,878,746 · Class: 11.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-001609
- Form type
- SCHEDULE 13G/A
- Filer
- ACADIA PHARMACEUTICALS INC
- CIK
- CIK 1070494
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership